The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the medical devices reimbursement market further?
The growing demand for minimally invasive surgeries is expected to propel the growth of the medical device reimbursement market going forward. Minimally invasive surgery (MIS) is a medical approach that utilizes specialized techniques and instruments to perform surgical procedures with the least disruption to the patient’s body compared to traditional open surgery. The benefits of medical device reimbursement for minimally invasive surgery include increased patient access to advanced procedures and reduced healthcare costs through shorter hospital stays. For instance, in September 2023, according to the American Society of Plastic Surgeons (ASPS), a US-based plastic surgery specialty organization, there were 4,715,716 minimally invasive procedures performed using botulinum toxin type A (including Botox, Dysport, and Xeomin) in 2023, reflecting a 6% increase from the previous year. Dermal fillers also saw significant use, with 3,441,534 procedures performed, up 4% from 2022. Therefore, the growing demand for minimally invasive surgeries is driving the growth of the medical device reimbursement market.
Medical Devices Reimbursement Market Driver: Chronic Disease Prevalence Drives Growth In Medical Device Reimbursement Market
The growing prevalence of chronic diseases is expected to propel the growth of the medical device reimbursement market going forward. Chronic diseases are long-term conditions that are typically manageable but not curable. Medical devices reimbursement is essential for managing chronic diseases by ensuring accessibility, fostering innovation, and improving patient outcomes while reducing economic burdens. For instance, in September 2024, the British Heart Foundation, a UK-based charity that funds research and raises awareness about heart and circulatory diseases, reported that approximately 7.6 million people in the UK are living with heart and circulatory diseases. It is forecasted that this number could increase by 1 million by 2030 and by 2 million more by 2040. Therefore, the growing prevalence of chronic diseases is driving the growth of the medical device reimbursement market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13481&type=smp
What are the key factors influencing the forecasted market size of the medical devices reimbursement industry?
The medical devices reimbursement market size has grown strongly in recent years. It will grow from $602.26 billion in 2024 to $653.64 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to government healthcare policies, increased disease burden, patient access and affordability, healthcare cost containment, provider and payer collaboration, increasing regulatory compliance.
The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $924.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to value-based healthcare models, rising demand for precision medicine, global health security initiatives, focus on patient-centric care, collaboration with health technology assessment (hta), government investments in healthcare. Major trends in the forecast period include integration of digital health technologies, collaborative agreements between manufacturers and payers, focus on real-world evidence and health economics data, adoption of pay-for-performance models, value assessment frameworks implementation, advancements in risk-sharing agreements.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13481&type=smp
Who are the leading competitors in the medical devices reimbursement market?
Major companies operating in the medical devices reimbursement market report are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Axa S.A., Assicurazioni Generali SpA, Humana Inc., Reliance Nippon Life Insurance Company Limited, MetLife Services and Solutions LLC, Aetna Inc., New York Life Insurance, Nationwide Mutual Insurance Company, American International Group Inc., Allstate Insurance Company, BNP Paribas S.A., Zurich Insurance Group Ltd., Aegon Life Insurance Company, Aviva PLC, WellCare Health Plans Inc., Pacific Life Insurance Company, Allianz SE, Bright House Financial Inc., Globe Life Inc., Munich Re Group, Symetra Life Insurance Company, Sumitomo Life Insurance Company, NAMSA Inc., Colonial Penn Life Insurance Company, Musculoskeletal Clinical Regulatory Advisers LLC, Assurity Life Insurance
Which emerging trends are set to transform the medical devices reimbursement market landscape?
Major companies operating in the medical device reimbursement market are focusing on developing technological advancements such as electronic medical records (EMR) to sustain their position in the market. Electronic medical records (EMRs) are digital versions of a patient’s paper medical charts, which are used to support reimbursement claims, ensuring that devices are medically necessary and appropriately utilized. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, launched the medicom-HRf hybrid cloud, an integrated electronic medical record (EMR) system that uses cloud technology to support location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf can seamlessly integrate various data sources, such as patient records, medical billing, insurance claims, and regulatory information. This integration provides a comprehensive view of patient treatment and billing history, crucial for accurate reimbursement. Medical device companies can access up-to-date information on insurance coverage, reimbursement rates, and claim status.
How do different geographies compare in terms of market share and growth potential in the medical devices reimbursement market?
North America was the largest region in the medical devices reimbursement market in 2024. The regions covered in the medical devices reimbursement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/medical-devices-reimbursement-global-market-report
Which major segments of the medical devices reimbursement market are experiencing the fastest growth?
The medical devices reimbursement market covered in this report is segmented –
1) By Payer: Public, Private
2) By Claims: Underpaid, Full
3) By Healthcare Setting: Hospitals, Outpatient Facilities, Other Healthcare Settings
Subsegments:
1) By Public: Government Health Insurance Programs, National Health Services, Social Health Insurance
2) By Private: Private Health Insurance Plans, Employer-Sponsored Health Insurance, Out-of-Pocket Reimbursement
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13481
How is the medical devices reimbursement market defined?
Medical device reimbursement refers to the process by which insurance plans or payers pay healthcare providers for providing medically necessary devices to patients. This process involves determining the cost of the device, evaluating its effectiveness, and negotiating with payers to ensure that the device is covered by insurance.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
